$RELT News: ONAR Announces ONAR LABS and Commercialization

New Post Public Reply Private Reply Replies (0) Message Board
Lee Adams
265
$RELT News: ONAR Announces ONAR LABS and Commercialization of Proprietary AI Marketing Platform Already Generating Results Across $200M+ in Cumulative Client Revenue

LOS ANGELES, Jan. 22, 2025 /PRNewswire/ -- ONAR (OTCQB: RELT) today announced the launch of ONAR Labs, the company's pioneering technology incubator, and unveiled its first product offering - Cortex, an AI-powered marketing intelligence platform that has been powering the company's agency network, was developed by Storia, and will become available to companies via subscription.

ONAR Labs, established as the company's dedicated innovation hub, will focus on developing and commercializing proprietary marketing technology solutions that have been battle-tested across ONAR's network of agencies. The launch of Cortex marks the first of several planned technology releases aimed at transforming how businesses leverage AI for marketing success.

"Cortex represents years of development and refinement across our agency portfolio," said Claude Zdanow, CEO of ONAR. "What began as an internal tool that drove exceptional results for our clients is now evolving into a commercial platform that will help enterprises remove marketing uncertainty and drive measurable growth through AI-powered intelligence."

Cortex's capabilities include:

Unified Performance Analytics: Real-time monitoring of cross-channel marketing KPIs with automated insights and alerts.
AI-Driven Marketing Forecasting: Predictive modeling that helps businesses anticipate performance trends and optimize campaign strategies.
Intelligent Attribution Modeling: Leverages technology that tracks and analyzes customer journeys across all marketing touchpoints, providing granular attribution insights that show the true impact of every marketing dollar spent - from first click to final conversion.
Multi-Channel Integration: Seamless connection with major platforms, including Google Ads, Meta, TikTok, LinkedIn, Pinterest, and other essential marketing tools.
The platform, which has been integral to the success of ONAR's agency network, and pioneered by ONAR's Storia agency, will be offered as a subscription service with tiered pricing based on business size and needs.

"Having leveraged Cortex's capabilities across our client portfolio, we've seen firsthand how AI-driven marketing intelligence can transform campaign performance," said Chris Becker, President of ONAR. "AI and machine learning is allowing us to unify data, predict trends, and automate insights at scale. It has been a game-changer for our team and clients."

ONAR Labs will operate as a dedicated division within ONAR, focused on identifying, developing, and commercializing innovative marketing technology solutions. The division will be staffed by a team of data scientists, engineers, and industry experts working alongside ONAR's agency professionals to ensure real-world applicability and impact.

"The launch of ONAR Labs and Cortex represents a significant milestone in our company's evolution," added Zdanow. "By commercializing our proprietary technology, we're not only creating a new revenue stream but also helping businesses of all sizes access enterprise-grade marketing intelligence tools that have been proven across our network."

Visit onar.com/labs for updates.

About ONAR

ONAR (OTCQB: RELT) is a dynamic marketing and business solutions network, currently publicly traded as Reliant Holdings, Inc. with plans to become Onar Holding Corporation in the near future. ONAR's mission is to provide unparalleled service through an integrated, AI-driven approach, leveraging its diverse brand family's strengths. Committed to honor, candor, and best-in-class results, ONAR aims to lead the industry by example, ensuring every client relationship is deeply rooted in trust and excellence.

ONAR has nearly 50 employees across five continents, and it is aggressively expanding its team to support the company's growth and acquisition pipeline. Its agencies service over 45 clients across various industries:

Performance Marketing & SEO: Our high-touch performance marketing agency, Storia, specializes in brand growth, data-driven excellence, and paid advertising.
Full-Service Healthcare Marketing: Partnering with healthcare professionals, Of Kos provides the best possible patient experience and strives to revolutionize the standard of care.
Experiential Marketing & Events: CHALK is an experiential marketing powerhouse of event architects who turn bold ideas into unforgettable reality, designing events that dare to defy the ordinary.
ONAR's network of agencies focuses on servicing companies ranging from $50M to $1B+ in revenue, and ONAR is actively searching for agencies to acquire and become part of the network.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are based on ONAR's current expectations and projections about future events and financial trends that it believes may affect its financial condition, results of operations, business strategy, and financial needs. These statements are not historical facts and are inherently uncertain and outside of ONAR's control. Forward-looking statements include, among other things, statements regarding ONAR's expectations regarding its ability to achieve its financial and strategic goals, including surpassing $100 million in revenue and securing a NASDAQ listing; its ability to expand its client base and market share; and its ability to develop and launch new products and services. Actual results may differ materially from ONAR's expectations and projections due to various risks and uncertainties, including market conditions, competition, the ability to protect intellectual property, the ability to manage growth, changes in laws and regulations, and other factors described in ONAR's filings with the Securities and Exchange Commission. These forward-looking statements are made as of the date of this press release, and ONAR undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/onar-announces-onar-labs-and-commercialization-of-proprietary-ai-marketing-platform-already-generating-results-across-200m-in-cumulative-client-revenue-302356835.html

SOURCE ONAR
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AI and Storytelling Make Waves in Science Education

Updated Category News Views 4

University's Innovative Approach to Learning Alright, here's something you don't see every day. The University of Phoenix managed to snag some kudos from an academic journal for using AI and storytelling to teach environmental science. That's like hitting two bulls-eyes with one shot in the world of education. The recognition from Glacies for this Editor's Choice paper...

Continue Reading
HONA Faces Legal Heat: Investor Lawsuit Over Losses

Updated Category News Views 5

The Investor Storm Brewing Over Honeywell Aerospace There it is again, another industry heavyweight caught in a dizzying whirlwind of litigation. Honeywell Aerospace Inc. (NASDAQ:HONA), a name as established as an old boot in the business, now faces a class action lawsuit that's got investors frantically dusting off phone numbers for their attorneys. The Messy Allegations...

Continue Reading
Geron Corp Faces Fiduciary Duty Investigation

Updated Category News Views 4

Spotlight on Geron's Corporate Governance: What's Happening? The heat's been turned up on Geron Corporation this week, with Halper Sadeh LLC, an investor rights law outfit, digging into whether some folks at the helm have strayed from their fiduciary duties to the shareholders. Now, if you're holding onto NASDAQ:GERN stock or thinking about diving in, it's high time to...

Continue Reading
Jackson Wang's Fantasy IP Hits Hong Kong Stage

Updated Category News Views 4

A Star-Studded Fantasy Comes Alive Hong Kong isn't just about dim sum and skyline views—it's a magnet for celebrity showcases, and this time, Jackson Wang's pulling the strings. The guy's ventured beyond music and idol fame, diving head-first into creative visuals with his fantasy IP, "Under the Castle" (UTC). Pairing up with Ocean Park's Halloween Fest, he's cooked up...

Continue Reading
Krispy Kreme Faces Legal Probe: Fiduciary Breach?

Updated Category News Views 3

Diving Deep into the Krispy Kreme Allegations Look, this isn't your run-of-the-mill donut drama. When you hear rumblings of corporate missteps, especially ones that involve potential breaches of fiduciary duties, it's time to perk up those ears. Over at Krispy Kreme, Inc. (NASDAQ:DNUT), there's some heat in the kitchen, and it's not just from frying those glazed beauties....

Continue Reading
Quay Sunglasses: Luxury Looks, Affordable Prices

Updated Category News Views 2

Ah, sunglasses—the quintessential accessory that screams both practicality and style. A million-dollar look without the million-dollar expense? That's where Quay comes in. They've been recognized by Expert Consumers, no less, as some of the best-in-class for affordable luxury eye candy out there—aimed at shoppers who want the designer vibe without the hemorrhaging...

Continue Reading
CVS Health Under Fire: Fiduciary Duty Breach?

Updated Category News Views 2

CVS Under Regulatory Spotlight for Fiduciary Breaches You'd think by now companies would have their fiduciary ducks in a row. But here we are, with CVS Health Corporation (NYSE: CVS) catching heat from the legal eagles over at Halper Sadeh LLC. The knife’s out for some of the big wigs – apparently, there's chatter they might’ve slipped on their duty to play nice...

Continue Reading
PACS Group Faces Legal Scrutiny: What to Watch

Updated Category News Views 3

PACS Group: Legal Storm Brewing Welcome to the latest saga in the volatile theater of corporate governance. PACS Group, Inc., ticker symbol NYSE:PACS, is under the microscope, and not for debuting a groundbreaking product or hitting a stock milestone. Nope, instead we've got Halper Sadeh LLC out of New York investigating some possible hanky-panky from PACS directors and...

Continue Reading

Top 5 Most Recently Viewed Articles

Ten Four Truck Insurance Welcomes Chris Johnstone on Board

Updated Category News Views 76

Exciting Leadership Move at Ten Four Truck Insurance Ten Four Truck Insurance, recognized as a premier provider of insurance solutions tailored specifically for the trucking industry, has recently elevated Chris Johnstone to the position of Director of Partnerships. This strategic appointment is set to enhance the company's collaborative efforts and broaden its partner...

Continue Reading
Innovative Screed Hook Design Enhances Concrete Pouring Process

Updated Category News Views 165

Revolutionizing the Concrete Construction Process In the bustling world of construction, efficiency is key. An inventive mind has recently introduced a specialized screed hook that promises to streamline the concrete pouring process significantly. This innovation is designed with a focus on ease of use, making it a practical addition for contractors and workers alike....

Continue Reading
SCR Expands Offerings Through Global Partnerships in Business Formation

Updated Category News Views 201

SCR Expands Offerings Through Global Partnerships In recent developments, SCR has made significant strides in enhancing its Offshore Company Formation services by forging international partnerships. These collaborations provide businesses and individuals with increased flexibility in establishing structures that can facilitate asset protection, succession planning, and...

Continue Reading
Response Pharmaceuticals Achieves Milestone in RDX-002 Study

Updated Category News Views 171

Response Pharmaceuticals Makes Significant Progress in Clinical Trial Response Pharmaceuticals, Inc., a company specializing in innovative weight management solutions, has announced a pivotal moment in its clinical trajectory. The firm has completed early enrollment in a Phase 2 clinical trial assessing the efficacy of its investigational drug candidate, RDX-002. This...

Continue Reading
Fifth Third Bancorp Faces Decline in Profit Due to Higher Provisions

Updated Category News Views 81

Fifth Third Bancorp Reports Lower Profits Amid Rising Provisions Fifth Third Bancorp (NASDAQ: FITB), a prominent financial institution, has reported a decrease in its profits for the third quarter, primarily influenced by heightened provisions for loan losses. The bank's recent financial disclosures have caught the attention of investors, culminating in a nearly 3% drop...

Continue Reading